Avelumab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	owl:NamedIndividual Orphan drug Pfizer brand Therapeutic monoclonal antibody Merck brand Monoclonal antibody for tumors Drug granted breakthrough therapy designation
rdfs:label	Avelumab
owl:sameAs	dbr:Avelumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Merck_brands http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/Category:Pfizer_brands http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies_for_tumors http://en.wikipedia.org/wiki/Cancer_immunotherapy http://en.wikipedia.org/wiki/Checkpoint_inhibitor http://en.wikipedia.org/wiki/PD-1_and_PD-L1_inhibitors http://en.wikipedia.org/wiki/Merkel-cell_carcinoma
skos:prefLabel	Avelumab
skos:altLabel	Bavencio avelumab
clgo:alternativeName	Bavencio
clgo:casNumber	1537032-82-8
clgo:drugbank	DB11945
clgo:fdaUniiCode	KXG2PJ551I
clgo:kegg	D10817
clgo:medlinePlus	a617006

About: clgr:Avelumab